Revolutionizing Urology Nano-Enhanced Motor Devices In Non-Muscle Invasive Bladder Cancer Management

E D I T O R I A L

Abstract

Abstract

Nanotechnology in urology is a revolutionary innovation in the management of non-muscle invasive bladder cancer (NMIBC). NMIBC is a difficult disease with a high rate of recurrence and progression; hence, its treatment is critical. Allopathic medicines, though, have some merits but at the same time have demerits and side effects that are not desirable. This editorial focuses on the application of nanotechnology improving the motor devices in NMIBC. These nanoscale devices have advanced motors that can move around on the surface of the bladder to apply the therapy on the affected regions that have cancer cells. This precision is made even more refined by using advanced imaging and artificial intelligence to enable the treatment to be delivered with even less collateral damage. The advantages of nanocarriers are due to their pharmacokinetic properties that allow enhancing the therapeutic efficacy and minimizing side effects.Real-time monitoring provides clinicians with the ability to modify the approach to the patient’s care as needed for the best outcomes. There are technical, regulatory, and economic barriers but the rewards of implementing this technology are numerous. However, the application of nanotechnology can be extended to cancer treatment in many other fields apart from urology. Therefore, motor devices based on nanotechnology are a major advancement in NMIBC treatment, which provides new opportunities for patients and doctors. These innovations are the hope for better results and fewer side effects as we move to this new age in medicine and the treatment of cancer.

Keywords: Nanotechnology, Urology, Bladder Cancer, Motor Devices, Precision Medicine